According to FutureWise analysis the market for Organ-on-Chip is expected to reach US$ 2.1 billion by 2031 at a CAGR of 31.30%.
Organ-on-chip (OoC) technology is a recent advancement that combines tissue engineering and stem cells with microfluidics, as well as the microfabrication of sensors and actuators. These OoC models aim to replicate aspects of human physiology and pathology, providing insights into the mechanisms behind drug responses and the onset and progression of diseases. Increasing evidence suggests that OoC devices can offer more accurate model systems for studying health and illness. Examples include vessels-on-chip, cancer-on-chip, kidney-on-chip, neurons-on-chip, lung-on-chip, and ALS-on-chip. OoC models are expected to be valuable in drug discovery, efficacy testing, toxicology, and even in precision or personalized medicine, especially with the use of patient-derived stem cells.
The OoC is a relatively new addition to the toolkit of model biological systems that are available to life science researchers to investigate many facets of human pathophysiology and illness. These systems span a range of physiological significance, with 3D cell cultures, organoids, and OoCs following 2D cell cultures in increasing relevance. Interestingly, using model species like mice and Drosophila to study physiology outperforms using synthetic tissue approaches. Unfortunately, this results in more challenging experiments because biological complexity rises with physiological relevance in model organisms. Despite major advancements in vivo imaging, in vivo physiological processes in mice, humans, and other mammals are often the least amenable to direct examination. The OoC could be seen as a bridging technology that allows for the use of complex cell cultures while also enabling better-tailored microenvironments to enhance the model.
According to the analysis conducted by FutureWise research analysts, the Organ-on-Chip market is estimated to register a considerable growth rate over the forecast period.
Request a Free Sample @ https://www.futurewiseresearch.com/contact.aspx?rpt=4099%20&type=requestsample
Organ-on-Chip Market Segmentation:
By Organ Type
- Lung-on-Chip
- Heart-on-Chip
- Liver-on-Chip
- Intestine-on-Chip
- Kidney-on-Chip
By Application
- Drug Discovery
- Toxicology Research
- Other Applications
By End-User
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Other End User
By Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Competitive Landscape in Organ-on-Chip Market:
- Altis Biosystems
- AxoSim Inc.
- Bi/ond
- BiomimX SRL
- Elveflow
- Emulate Inc.
- Hesperos
- Hurel Corporation
- Allevi Inc.
- InSphero AG
- Mimetas BV
- Netri
- Nortis Inc.
- Tara Biosystems Inc.
- TissUse GmbH
Buy now the latest version of this report:
https://www.futurewiseresearch.com/checkout.aspx?ReportId=4099&license=multi
**Objectives of this Study: **
- To provide a comprehensive analysis of the Organ-on-Chip Market By Organ Type, By Application, By End-User and By Region.
- To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
- To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
- To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Flexible Delivery Model:
- We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
- The customization services offered are free of charge with the purchase of any license of the report.
- You can directly share your requirements/changes to the current table of contents to: sales@futurewiseresearch.com
